CureGenetics
Cure Genetics (克睿基因) is a clinical-stage biotechnology company founded in 2016 and based in Suzhou, Jiangsu, China, developing cell and gene therapies for solid tumors and genetic diseases. Its differentiated pipeline is built on two proprietary platforms: AIMS CAR-NKT, a cell-therapy approach engin
CureGenetics is an API provider whose private shares are listed on 2 secondary markets: EquityZen, Nasdaq Private Market.
Where It Trades
Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.
Work with this as data
Every listing here is available over the APIs.io API and to AI agents over MCP. Secondary Market is not yet its own endpoint on the v1 API. Reach it through catalog search and the tag graph, or the MCP server.
MCP server
One button, every client — Claude, Cursor, VS Code and the rest.
https://apis.io/mcp
Tools for secondary market
3 MCP tools reach this
apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.resolveTurn a domain, URL or GitHub org into the provider it belongs to.find_cohortsEvery scored population of providers in the catalog.
Call it yourself
curl for this page
curl "https://apis.io/api/v1/search?q=curegenetics&limit=10"curl "https://apis.io/api/v1/tags/curegenetics"Discovery needs no key. Ratings and market analysis are Pro.